SGBCF 财务： Shanghai Henlius Biotech Inc AI 分析

主页

股票

SGBCF

SGBCF 财务

Shanghai Henlius Biotech Inc

0%

$0

收盘价：Feb 13, 16:00:00 GMT-5

0%

$0

盘后：Feb 13, 20:00:00 GMT-5

概述预测收益股息财务数据

关键数据

前收盘价

开盘价

当日区间

52周范围

交易量

平均成交量

每股收益（TTM）

股息收益率

市值

什么是 SGBCF？

Shanghai Henlius Biotech, Inc. engages in the production and sale of monoclonal antibody (mAb) drugs and the provision of related consultation and technical services, and the transfer of its own technology. The company is headquartered in Shanghai, Shanghai and currently employs 3,537 full-time employees. The company went IPO on 2019-09-25. The Company’s main products include HANQUYOU (trastuzumab for injection), HANNAIJIA (neratinib maleate), HANSIZHUANG (serplulimab injection), HANLIKANG (rituximab injection), HANDAYUAN (adalimumab injection), HANBEITAI (bevacizumab injection) and others. The Company’s products are mainly used in the treatment of adjuvant breast cancer, metastatic breast cancer, metastatic gastric cancer, metastatic non-squamous non-small cell lung cancer, polyarticular juvenile idiopathic arthritis and others. The firm mainly operates its businesses in the domestic and overseas markets.

功能特性

资源

市场

收入

资产负债表

现金流量

年度

季度性

SGBCF 收入

以百万美元为单位的财务数据。财年为2月至次年1月。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
营收	5,797	5,724	5,394	3,214	1,682	587
营收同比增长 (YoY)	3%	6%	68%	91%	187%	552%
营收成本	1,404	1,539	1,476	844	522	182
毛利润	4,393	4,184	3,918	2,370	1,159	405
销售、一般及管理费用	2,401	2,283	2,168	1,404	801	436
研发	1,138	1,035	1,118	1,394	1,023	894
营业费用	3,462	3,245	3,245	2,994	2,034	1,362
其他非经营性收入 (费用)	--	--	--	--	--	--
税前利润	843	845	569	-693	-956	-993
所得税费用	19	25	23	1	27	0
净利润	824	820	546	-695	-984	-993
净利润增长	19%	50%	-179%	-28.99%	-1%	13%
稀释后流通股数	543.49	543.49	543.37	542.02	538.83	529.57
股份同比变动 (YoY)	0%	0%	0%	1%	2%	7%
每股收益 (摊薄)	1.51	1.5	1	-1.28	-1.82	-1.87
每股收益增长率	19%	50%	-178%	-30%	-3%	7%
自由现金流	753	404	36	-383	-1,040	-1,166
每股自由现金流	--	--	--	--	--	--
毛利率	75.78%	73.09%	72.63%	73.73%	68.9%	68.99%
营业利润率	16.06%	16.38%	12.47%	-19.41%	-51.96%	-163.03%
净利率	14.21%	14.32%	10.12%	-21.62%	-58.5%	-169.16%
自由现金流利润率	12.98%	7.05%	0.66%	-11.91%	-61.83%	-198.63%
EBITDA	1,353	1,312	1,032	-347	-674	-822
EBITDA 利润率	23.33%	22.92%	19.13%	-10.79%	-40.07%	-140.03%
EBITDA 中的折旧与摊销	422	374	359	277	200	135
EBIT	931	938	673	-624	-874	-957
EBIT 利润率	16.06%	16.38%	12.47%	-19.41%	-51.96%	-163.03%
有效税率	2.25%	2.95%	4.04%	-0.14%	-2.82%	0%

Shanghai Henlius Biotech Inc（SGBCF）价格

SGBCF 股价走势图